Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Chronic mesenteric ischaemia

Gastroenterology and hepatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

A change from postprandial pain to sudden, severe, continuous or disproportionate pain, especially with vomiting, gastrointestinal bleeding, guarding, acidosis or shock, is acute-on-chronic mesenteric ischaemia. Begin emergency resuscitation, obtain immediate CT angiography and involve vascular and general surgery without delay.

Synopsis

Recognise food-related mesenteric angina before acute thrombosis, distinguish symptomatic multivessel atherosclerosis from incidental stenosis, obtain CTA and nutritional assessment promptly, and coordinate revascularisation with cardiovascular secondary prevention.

  • Typical chronic mesenteric ischaemia causes reproducible postprandial epigastric or central pain, food fear and progressive weight loss in a person with systemic atherosclerotic risk.
  • Symptoms often begin 15 to 30 minutes after eating and can last hours; smaller meals reduce demand and may temporarily mask the disease.
  • A bruit is neither sensitive nor specific. Normal examination, endoscopy or routine blood tests do not exclude flow-limiting mesenteric disease.
  • CTA is the usual anatomical first-line test, showing coeliac and superior mesenteric origins, collateral pathways, calcification and competing abdominal disease.
  • Single-vessel stenosis is common and can be incidental; symptom concordance, severity, multivessel involvement and exclusion of alternatives determine causality.
  • Sudden persistent pain, peritonism, gastrointestinal bleeding or metabolic deterioration suggests acute-on-chronic ischaemia and requires emergency CTA and surgery.
  • Definitive treatment restores flow with endovascular or open revascularisation; nutritional supplements alone cannot overcome demand ischaemia.
  • Smoking cessation, antiplatelet therapy, lipid lowering, blood-pressure and diabetes care continue after intervention because this is systemic atherosclerosis.

Key red flags

Acute-on-chronic event

Pain becomes sudden, severe, continuous or disproportionate, with vomiting, blood, guarding, acidosis or shock. Treat as acute mesenteric ischaemia immediately.

Severe malnutrition

Sarcopenia, dehydration, deficiency, frailty or inability to eat increases procedural risk and requires dietetic support without postponing definitive vascular assessment.

Investigation priorities

01
CT angiographyFirst step

Map coeliac, SMA and IMA stenosis or occlusion, calcification, collateral vessels and bowel or alternative abdominal pathology.

Management branches

RecognisePostprandial pain and weight loss

A patient has reproducible meal-related pain, food fear or unexplained weight loss with vascular risk.

  1. Assess acute-on-chronic warning signs and use emergency CTA if pain is persistent, disproportionate or accompanied by peritonism or organ dysfunction.
  2. For a stable syndrome, request CTA and evaluate cancer, pancreatic, peptic and biliary alternatives in parallel according to the phenotype.
  3. Start dietetic support with small energy-dense intake and refeeding precautions when needed, without allowing supplements to delay vascular review.
  4. Refer promptly to a vascular multidisciplinary service with the images and functional nutrition impact.

Key medicines

Antiplatelet therapyUse the current BNF and vascular-team regimen, commonly single antiplatelet before intervention and a device-specific plan after stenting.Gastrointestinal bleeding, allergy and concurrent anticoagulation require review. Do not improvise dual-therapy duration; the intervention team owns it.
High-intensity statinUse the current NICE NG238 secondary-prevention regimen and titrate to response, interactions and tolerance.Review muscle symptoms, liver context and major interactions; do not stop after revascularisation because the systemic disease persists.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • RCR clinical radiology gastrointestinal and vascular curriculumUK imaging-pathway competencies for chronic gastrointestinal ischaemia; modality decisions still require current local radiology.
  • NICE NG238: Cardiovascular risk reductionCurrent lipid, smoking and cardiovascular secondary-prevention framework.
  • BNF: Antiplatelet drugsCurrent UK antiplatelet contraindication and interaction context.
  • NICE NG12: Suspected cancerParallel evaluation of weight loss and gastrointestinal alarm features.
  • NICE CG32: Nutrition supportMalnutrition and refeeding prevention around revascularisation.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom